-
Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of third hypervariable env region.
J Immunol. 1990 Nov 15;145(10):3240-6
PMID: 1700002
-
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees.
J Virol. 1990 Aug;64(8):3779-91
PMID: 2370681
-
Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes.
Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3097-101
PMID: 2014229
-
Generation of diversity in retroviruses.
Annu Rev Genet. 1990;24:409-45
PMID: 1708222
-
Neutralization of HIV-1: a paradox of humoral proportions.
FASEB J. 1991 Jul;5(10):2437-55
PMID: 1712328
-
Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody.
Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8949-52
PMID: 1717992
-
Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120.
J Virol. 1992 Feb;66(2):848-56
PMID: 1370558
-
Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies.
AIDS Res Hum Retroviruses. 1992 Jun;8(6):1147-51
PMID: 1380261
-
Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus.
AIDS Res Hum Retroviruses. 1992 Jun;8(6):1165-70
PMID: 1380263
-
Complex intrapatient sequence variation in the V1 and V2 hypervariable regions of the HIV-1 gp 120 envelope sequence.
Virology. 1992 Dec;191(2):837-45
PMID: 1448927
-
Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein.
J Virol. 1993 May;67(5):2747-55
PMID: 8474172
-
The role of the V3 loop of gp120 in HIV infection.
AIDS. 1991;5 Suppl 2:S21-33
PMID: 1845049
-
Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody.
J Virol. 1993 Jun;67(6):3674-9
PMID: 8497077
-
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding.
J Virol. 1993 Jul;67(7):3978-88
PMID: 7685405
-
Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys.
J Virol. 1993 Jul;67(7):4104-13
PMID: 8510218
-
Biological cloning of functionally diverse quasispecies of HIV-1.
AIDS Res Hum Retroviruses. 1993 Jun;9(6):541-6
PMID: 8347398
-
Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains.
J Virol. 1993 Oct;67(10):6136-51
PMID: 7690418
-
Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies.
J Virol. 1993 Nov;67(11):6897-902
PMID: 8411395
-
Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.
J Virol. 1994 Jan;68(1):469-84
PMID: 7504741
-
Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.
Science. 1985 May 31;228(4703):1091-4
PMID: 2986290
-
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.
Cell. 1986 Jun 6;45(5):637-48
PMID: 2423250
-
Genetic variation in AIDS viruses.
Cell. 1986 Jul 4;46(1):1-4
PMID: 3013415
-
Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.
J Virol. 1987 Feb;61(2):570-8
PMID: 2433466
-
Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene.
Cell. 1988 Jul 1;54(1):57-63
PMID: 2838179
-
Differential neutralizing capacity to different human immunodeficiency virus (HIV) isolates by a rabbit antiserum against LAV: sensitive assays with HTLV-I-positive MT-4 cells.
AIDS Res Hum Retroviruses. 1988 Apr;4(2):91-8
PMID: 3284555
-
Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients.
Science. 1985 May 3;228(4699):593-5
PMID: 2984774
-
Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
Nature. 1990 Jun 14;345(6276):622-5
PMID: 2190095
-
Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.
AIDS. 1990 Apr;4(4):307-15
PMID: 2190605
-
The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope.
J Virol. 1990 Jul;64(7):3240-8
PMID: 2352323
-
Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.
J Biol Chem. 1990 Jun 25;265(18):10373-82
PMID: 2355006
-
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):542-6
PMID: 1988952